Nu Skin Enterprises, Inc. (NYSE:NUS)
CAPS Rating:
A global direct selling company with operations throughout Asia, the Americas and Europe. The Company develops and distributes personal care products and nutritional supplements sold under the Nu Skin and Pharmanex brands.
RSS Headlines
Fool UK
Recs
It has barely penetrated that U.S. market compared to europe and asia and, as the economy & consumer confidence pick up, this stock will attract more attention and volume should increase. Share price has gone from about $7 to $30 in less than two years, but there is room for upside.
This company ROCKS! They have 10x's out performed any other skincare product launch in history. The increase is due to a breakthrough in anti-aging technology called ageLOC which regulates the genetics of aging. NuSkin will launch a supplement in Feb 2010 designed to influence the mitochondria which should take them from $7.00 two years ago to over $100 by the first quarter next year. All I have to say is INVEST NOW!